Pyridostigmine Bromide
NDC 62559-470, Pyridostigmine Bromide, tablet, from ANI Pharmaceuticals, Inc..
- Product NDC
- 62559-470
- Status
- Listed
- Labeler
- ANI Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA040512
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62559-470 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PYRIDOSTIGMINE BROMIDE60 mg/1
Pharmacologic classes
Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62559-470-01 | 62559047001 | 100 TABLET in 1 BOTTLE (62559-470-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0a114d99-e50b-49fe-9e0f-ccce279ffb4fNADAC price for package 62559047001
GET /v1/drugs/nadac/62559047001
Use it
Look up 62559-470 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62559-470 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62559-470. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.